342 related articles for article (PubMed ID: 29101553)
1. Treatment Options for Resistant Kawasaki Disease.
Phuong LK; Curtis N; Gowdie P; Akikusa J; Burgner D
Paediatr Drugs; 2018 Feb; 20(1):59-80. PubMed ID: 29101553
[TBL] [Abstract][Full Text] [Related]
2. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease: a comprehensive review of treatment options.
Patel RM; Shulman ST
J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
[TBL] [Abstract][Full Text] [Related]
4. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
Servel AC; Vincenti M; Darras JP; Lalande M; Rodière M; Filleron A
Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.
Yang X; Liu G; Huang Y; Chen S; Du J; Jin H
Cardiol Young; 2015 Aug; 25(6):1182-90. PubMed ID: 25597708
[TBL] [Abstract][Full Text] [Related]
6. [Pediatric expert consensus on the application of aspirin in Kawasaki disease].
; ; ; ; ; ; ; ; ;
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):597-603. PubMed ID: 35652428
[TBL] [Abstract][Full Text] [Related]
7. Transient Deformation of Neutrophils in Kawasaki Disease.
Koike Y; Yanagisawa R; Ogiso Y; Cho Y; Minami K; Takeuchi K; Sakashita K; Higuchi T
J Pediatr; 2016 Jun; 173():238-241.e1. PubMed ID: 27039225
[TBL] [Abstract][Full Text] [Related]
8. Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
Bayers S; Shulman ST; Paller AS
J Am Acad Dermatol; 2013 Oct; 69(4):501.e1-11; quiz 511-2. PubMed ID: 24034379
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.
Chandelia S
Cardiol Young; 2015 Aug; 25(6):1228. PubMed ID: 25904322
[No Abstract] [Full Text] [Related]
10. Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease.
; ; ; ; ;
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Sept 15; 23(9):867-876. PubMed ID: 34535199
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Kawasaki Disease: Mind the Age, But It Does Not Matter.
Kamal S; Khan MA; Altorok N
J Clin Rheumatol; 2016 Jun; 22(4):223-4. PubMed ID: 27219316
[No Abstract] [Full Text] [Related]
12. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
13. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
Li X; Chen Y; Tang Y; Ding Y; Xu Q; Sun L; Qian W; Qian G; Qin L; Lv H
Eur J Pediatr; 2018 Aug; 177(8):1279-1292. PubMed ID: 29948255
[TBL] [Abstract][Full Text] [Related]
14. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
Chen HH; Liu PM; Bong CN; Wu YT; Yang KD; Wang CL
J Microbiol Immunol Infect; 2005 Apr; 38(2):149-52. PubMed ID: 15843862
[TBL] [Abstract][Full Text] [Related]
15. A case report of refractory kawasaki disease.
Ng SH; Roshan S
Med J Malaysia; 2018 Dec; 73(6):410-412. PubMed ID: 30647216
[TBL] [Abstract][Full Text] [Related]
16. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
Zhang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823
[No Abstract] [Full Text] [Related]
17. Lessons learned from an animal model of Kawasaki disease.
Yeung RS
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S69-71. PubMed ID: 17428374
[TBL] [Abstract][Full Text] [Related]
18. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.
Son MB; Gauvreau K; Burns JC; Corinaldesi E; Tremoulet AH; Watson VE; Baker A; Fulton DR; Sundel RP; Newburger JW
J Pediatr; 2011 Apr; 158(4):644-649.e1. PubMed ID: 21129756
[TBL] [Abstract][Full Text] [Related]
19. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[TBL] [Abstract][Full Text] [Related]
20. [Immunoglobulin in suspected Kawasaki disease].
García Soblechero E; Gómez Santos E; Domínguez Quintero ML; González Vila L
An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
